Letter to Editor
Year 2022,
Volume: 5 Issue: 1, 76 - 78, 30.04.2022
Abstract
Radikal sistektomi kas invaziv non-metastatik mesane kanserleri için standart tedavidir. İskemik kalp hastalığı, dünya çapında morbidite ve mortalitenin en yaygın nedenleri arasındadır. Bu olguda invaziv mesane kanseri nedeniyle radikal sistektomi üriner diversiyon uygulanan ciddi kalp yetmezliği bulunan bir hastada perioperatif anestezi yönetimimiz aktarılmıştır.
References
- Referans1. Vetterlein MW, Gild P, Kluth LA, et al. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2018;121:101-10. 10.1111/bju.14012.
- Referans2. Joensen UN, Maibom SL and Poulsen AM. Surgical Management of Muscle Invasive Bladder Cancer: A Review of Current Recommendations. Semin Oncol Nurs. 2021;37:151104. 10.1016/j.soncn.2020.151104.
- Referans3. Writing Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-327. 10.1161/CIR.0b013e31829e8776.
- Referans4. Moroni F, Gertz Z and Azzalini L. Relief of Ischemia in Ischemic Cardiomyopathy. Curr Cardiol Rep. 2021;23:80. 10.1007/s11886-021-01520-4.
- Referans5. Malik A, Brito D and Chhabra L. Congestive Heart Failure. In: StatPearls, Treasure Island (FL): 2021, p.
- Referans6. Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164-74. 10.1016/j.eururo.2008.07.031.
- Referans7. Yannick Cerantola, Massimo Valerio, Beata Persson, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. Clin Nutr. 2013 Dec;32(6):879-87. doi: 10.1016/j.clnu.2013.09.014.Epub 2013 Oct 17.
Year 2022,
Volume: 5 Issue: 1, 76 - 78, 30.04.2022
Abstract
References
- Referans1. Vetterlein MW, Gild P, Kluth LA, et al. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2018;121:101-10. 10.1111/bju.14012.
- Referans2. Joensen UN, Maibom SL and Poulsen AM. Surgical Management of Muscle Invasive Bladder Cancer: A Review of Current Recommendations. Semin Oncol Nurs. 2021;37:151104. 10.1016/j.soncn.2020.151104.
- Referans3. Writing Committee M, Yancy CW, Jessup M, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128:e240-327. 10.1161/CIR.0b013e31829e8776.
- Referans4. Moroni F, Gertz Z and Azzalini L. Relief of Ischemia in Ischemic Cardiomyopathy. Curr Cardiol Rep. 2021;23:80. 10.1007/s11886-021-01520-4.
- Referans5. Malik A, Brito D and Chhabra L. Congestive Heart Failure. In: StatPearls, Treasure Island (FL): 2021, p.
- Referans6. Shabsigh A, Korets R, Vora KC, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164-74. 10.1016/j.eururo.2008.07.031.
- Referans7. Yannick Cerantola, Massimo Valerio, Beata Persson, et al. Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS(®)) society recommendations. Clin Nutr. 2013 Dec;32(6):879-87. doi: 10.1016/j.clnu.2013.09.014.Epub 2013 Oct 17.
There are 7 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Subjects | Anaesthesiology |
| Journal Section | Letter to Editor |
| Authors | |
| Publication Date | April 30, 2022 |
| Acceptance Date | April 10, 2022 |
| Published in Issue | Year 2022 Volume: 5 Issue: 1 |
You are free to:
Share — copy and redistribute the material in any medium or format The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.